Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolios
Close

Cns Pharmaceuticals Inc (CNSP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cns Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.225 +0.033    +17.07%
16/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.222
-0.003
-1.333%
0:43:42 - Real-time Data
  • Volume: 327,128
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.192 - 0.229
Type:  Equity
Market:  United States
Cns Pharma 0.225 +0.033 +17.07%

Cns Pharma Company Profile

 
Read the Cns Pharmaceuticals Inc company profile to learn more about the business and the management team. View Cns Pharmaceuticals Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

4

Equity Type

ORD

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company’s lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. CNS Pharmaceuticals, Inc. has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

Contact Information

Address 2100 West Loop South Suite 900
Houston, 77027
United States
Phone 800 946 9185
Fax -

Top Executives

Name Age Since Title
John Michael Climaco 52 2017 Chairman of the Board, CEO & President
Jerzy George Gumulka 73 2017 Independent Director
Bettina M. Cockroft 56 2023 Independent Director
Sigmund Hsu - - Scientific Advisory Board Member
Amy Mahery - 2024 Independent Director
Jeffry R. Keyes 51 2018 Independent Director
Carl Anthony Evans 76 2018 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CNSP Price Commentary

Write your thoughts about Cns Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Johnhenry Marsh
Johnhenry Marsh Jun 07, 2023 21:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
think the big boys will push it up Fri ,b4 taking profits at end of day!!!
Johnhenry Marsh
Johnhenry Marsh Jun 02, 2023 18:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
more to come
Johnhenry Marsh
Johnhenry Marsh May 12, 2022 18:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wrong tea leafs
Johnhenry Marsh
Johnhenry Marsh May 12, 2022 18:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's a sleeping mover
Johnhenry Marsh
Johnhenry Marsh Apr 12, 2022 7:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hoping for .45 by end of April
Johnhenry Marsh
Johnhenry Marsh Jun 22, 2021 0:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it due for a rise
tarabjit singh
tarabjit singh Jan 07, 2021 18:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wait and watch bullish stock
tarabjit singh
tarabjit singh Jan 07, 2021 18:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jan 7 i mentioned its bullish now see the trend henceforth..
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email